Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors. 

Information Technology

Ribometrix

Mike Solomon

Barry Wilson

Sarah Thompson

Katie Warner

Murty Changalvala

Ramamurty Changalvala

Kevin Weeks

Orshi Kocsis

Jessica Sorrentino

Barclay Phillips

Ribometrix's executive team has experience in the biotechnology industry, with a focus on chemistry and organic chemistry. They have experience working in venture capital, as well as in startups. Additionally, they have experience as an entrepreneur and as a Chief Operating Officer.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Ribometrix

Board of Directors

Leadership Team